{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T16:26:11Z","timestamp":1764433571935,"version":"3.33.0"},"reference-count":27,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Intl J Gynecology &amp; Obste"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Iron deficiency anemia is an important problem among pregnant women, and intravenous (IV) iron infusions have been increasingly used. Whether fetal monitoring is required during infusion has been debated, with a recent guideline by Hematologists recommending against such. We report two cases of fetal bradycardia after iron isomaltoside (IIM), in women with otherwise good maternal and fetal health. Both developed dyspnea with desaturation minutes from infusion, followed by persistent fetal bradycardia. Both underwent category 1 CS, with cord arterial pH of 7.08 and 6.94 respectively. Upon literature review, only three case reports on fetal bradycardia in IV iron were identified. For older IV iron formulations, a case was reported after IV dextran test dose, while two cases after ferric gluconate were reported. For the new formulation IIM, only one case was reported so far, but in a woman with Crohn's disease and intrauterine growth restriction. IV iron in pregnancy carries risk of anaphylactic or hypersensitivity reactions, even with the newest formulations and in women with good maternal and fetal health. While rarely reported so far, fetal bradycardia is a possible consequence, commonly preceded by respiratory symptoms. Fetal monitoring should therefore be considered during infusion.<\/jats:p>","DOI":"10.1002\/ijgo.15855","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T07:21:25Z","timestamp":1723188085000},"page":"82-86","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Fetal bradycardia and acidosis during maternal parenteral iron: Case reports and literature review"],"prefix":"10.1002","volume":"168","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0211-0831","authenticated-orcid":false,"given":"Linus L. T.","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology Pamela Youde Nethersole Eastern Hospital  Chai Wan Hong Kong"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Ying","family":"Law","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology Pamela Youde Nethersole Eastern Hospital  Chai Wan Hong Kong"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin Wai","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology Pamela Youde Nethersole Eastern Hospital  Chai Wan Hong Kong"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,8,9]]},"reference":[{"key":"e_1_2_8_2_1","unstructured":"International Federation of Gynecology and Obstetrics.Iron Deficiency and Anemia in Women and Girls.2023. Accessed Mar 9 2024."},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27220"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.847693"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13252"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1159\/000495978"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16221"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.15572"},{"key":"e_1_2_8_9_1","first-page":"137","article-title":"Prevention and management of acute reactions to intravenous iron in surgical patients","volume":"17","author":"G\u00f3mez\u2010Ram\u00edrez S","year":"2018","journal-title":"Blood Transfus"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-023-01548-2"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-018-0769-5"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-151048"},{"key":"e_1_2_8_13_1","unstructured":"Therapeutic Goods Administration.Parenteral Iron Products: Fetal Bradycardia and Kounis Syndrome. TGA website. Accessed Mar 9 2024.https:\/\/www.tga.gov.au\/news\/safety\u2010updates\/parenteral\u2010iron\u2010products\u2010fetal\u2010bradycardia\u2010and\u2010kounis\u2010syndrome"},{"key":"e_1_2_8_14_1","unstructured":"European Medicines Agency.Iron (Parenteral Preparations): CMDh Scientific Conclusions and Grounds for the Variation to the terms of the Marketing Authorisation(s).2019. Accessed Mar 9 2024."},{"volume-title":"Ferric Derisomaltose Pharmacosmos 100 mg\/ml Solution for Injection\/Infusion. Summary of Product Characteristics","year":"2023","key":"e_1_2_8_15_1"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11111060"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajo.12695"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-022-06768-x"},{"issue":"48","key":"e_1_2_8_19_1","first-page":"A5264","article-title":"Anaphylaxis after iron dextran administration in a pregnant woman","volume":"156","author":"Kortenhorst MSQ","year":"2012","journal-title":"Ned Tijdschr Geneeskd"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijoa.2015.01.008"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/FM9.0000000000000151"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.106446"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijoa.2005.05.001"},{"issue":"3","key":"e_1_2_8_24_1","first-page":"296","article-title":"Safety of intravenous iron formulations: facts and folklore","volume":"12","author":"Auerbach M","year":"2014","journal-title":"Blood Transfus"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.3390\/children9101473"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph11030082"},{"issue":"2","key":"e_1_2_8_27_1","first-page":"173","article-title":"Iron parenteral administration: an expert opinion on the assessment of fetal wellbeing","volume":"20","author":"Ragusa A","year":"2022","journal-title":"Blood Transfus"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.111492"}],"container-title":["International Journal of Gynecology &amp; Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijgo.15855","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T12:19:14Z","timestamp":1737116354000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1002\/ijgo.15855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,9]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1002\/ijgo.15855"],"URL":"https:\/\/doi.org\/10.1002\/ijgo.15855","archive":["Portico"],"relation":{},"ISSN":["0020-7292","1879-3479"],"issn-type":[{"type":"print","value":"0020-7292"},{"type":"electronic","value":"1879-3479"}],"subject":[],"published":{"date-parts":[[2024,8,9]]},"assertion":[{"value":"2024-05-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}